Delivery order 3: procurement of nilotinib tablets in support of the dhhs, NIH, NCI, dctd, ctep. 150 MG tablets: 240 blister packs 200 MG tablets: 40 blister packs

Ended Awarded Last action

Contract number
75N91024F00001
Awardee
Awarding agency
Obligated
$1,707,050

Award facts

Contract value 100% obligated
$1,707,050.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Frederick, MD 21703, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $1.7 million delivery order contract to Regimed Medical to procure 240 blister packs of 150 mg nilotinib tablets and 40 blister packs of 200 mg nilotinib tablets in support of the Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program. The firm fixed price contract runs from November 17, 2023 through November 16, 2024 and will be performed in Frederick, Maryland.

Quick answers

Who was awarded contract 75N91024F00001?

75N91024F00001 was awarded to Regimed Medical by National Cancer Institute (National Institutes of Health) on November 17, 2023.

How much is contract 75N91024F00001 worth?

The government has obligated $1,707,050 on 75N91024F00001.

Is contract 75N91024F00001 an order under another contract?

Yes. 75N91024F00001 is a delivery order under 75N91023D00005, an indefinite delivery contract.

Was contract 75N91024F00001 competed?

The extent of competition for 75N91024F00001 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award